MOLECULAR CHARACTERIZATION OF THE RHODOPSIN GENE

视紫红质基因的分子特征

基本信息

项目摘要

The relationship of the structural features of the rhodopsin gene and the molecular mechanisms regulating its expression, to phototransduction and to the survival of photoreceptor cells are important neurobiological problems about which relatively little is known. The overall objective of this 5 year research plan is to characterize the molecular structure and function of the mouse rhodopsin gene. This includes studies on the regulation of its expression by genetic and environmental (light vs. dark) factors and the investigation of the mechanisms controlling its expression during development of normal mice and of mice with inherited visual defects. The amounts of mRNA for opsin and 48k (S-antigen, Arrestin) are regulated in a non-coordinate manner by light and/or the light/dark cycle to which the animal is exposed. In addition, the localization of a number of photoreceptor specific proteins in the rod inner and outer segments is transient and dependent on light. The relationship between the changes in concentration of mRNAs and photoreceptor specific proteins with respect to development, genotype, and light will be determined by Western and Northern analysis and by immunocytochemistry. The mouse opsin gene has been cloned and sequenced, and putative regulatory sequence demonstrated. Cis-acting nucleotide sequences and trans-acting factors which participate in the light mediated responses will be identified using DNA retardation assays and transfection studies. The exact chromosomal loci for the genes for mouse rhodopsin and 48k will be determined using Southern analysis of restriction digests of genomic DNA from Chinese hamster-mouse somatic cell hybrids and from recombinant inbred lines of mice. The structure and expression of these genes will be examined in mice with mutations which map at or near to their loci. The nucleotide sequences of identified allelic forms of the rhodopsin gene will be determined and the qualitative and quantitative activity of the rhodopsin gene determined for these genes alone, and in combination with mutations (rd and rds) which cause inherited retinal degeneration and transcriptional and post transcriptional effects on the expression of the opsin gene, prior to the death of the photoreceptor cells. The molecular structure and function of the five transcripts from the mouse rhodopsin gene will be determined in normal and mutant mice. The data generated by this project may increase our understanding of the normal process of phototransduction in man and/or the molecular pathology of inherited retinal degeneration.
视紫红质基因的结构特征与

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES Francis MCGINNIS其他文献

JAMES Francis MCGINNIS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES Francis MCGINNIS', 18)}}的其他基金

Prolonged Inhibition of Pathologic Neovascularization by Catalytic Antioxidants
催化抗氧化剂对病理性新血管形成的长期抑制
  • 批准号:
    8607958
  • 财政年份:
    2012
  • 资助金额:
    $ 22.49万
  • 项目类别:
Prolonged Inhibition of Pathologic Neovascularization by Catalytic Antioxidants
催化抗氧化剂对病理性新血管形成的长期抑制
  • 批准号:
    8222309
  • 财政年份:
    2012
  • 资助金额:
    $ 22.49万
  • 项目类别:
Prolonged Inhibition of Pathologic Neovascularization by Catalytic Antioxidants
催化抗氧化剂对病理性新血管形成的长期抑制
  • 批准号:
    8415878
  • 财政年份:
    2012
  • 资助金额:
    $ 22.49万
  • 项目类别:
Prolonged Inhibition of Pathologic Neovascularization by Catalytic Antioxidants
催化抗氧化剂对病理性新血管形成的长期抑制
  • 批准号:
    8798665
  • 财政年份:
    2012
  • 资助金额:
    $ 22.49万
  • 项目类别:
Cellular Imaging and Morphometric Analysis Core
细胞成像和形态测量分析核心
  • 批准号:
    10011811
  • 财政年份:
    2011
  • 资助金额:
    $ 22.49万
  • 项目类别:
COBRE:OUHSC: IMAGE ACQUISITION & PRODUCTION CORE
COBRE:OUHSC:图像采集
  • 批准号:
    8360403
  • 财政年份:
    2011
  • 资助金额:
    $ 22.49万
  • 项目类别:
COBRE:OUHSC: IMAGE ACQUISITION & PRODUCTION CORE
COBRE:OUHSC:图像采集
  • 批准号:
    8168347
  • 财政年份:
    2010
  • 资助金额:
    $ 22.49万
  • 项目类别:
Prevention of Inherited Retinal Diseases by Therapeutic Rare Earth Nanoparticles
通过治疗性稀土纳米颗粒预防遗传性视网膜疾病
  • 批准号:
    7583201
  • 财政年份:
    2009
  • 资助金额:
    $ 22.49万
  • 项目类别:
COBRE:OUHSC: IMAGE ACQUISITION & PRODUCTION CORE
COBRE:OUHSC:图像采集
  • 批准号:
    7959974
  • 财政年份:
    2009
  • 资助金额:
    $ 22.49万
  • 项目类别:
Prevention of Inherited Retinal Diseases by Therapeutic Rare Earth Nanoparticles
通过治疗性稀土纳米颗粒预防遗传性视网膜疾病
  • 批准号:
    7895588
  • 财政年份:
    2009
  • 资助金额:
    $ 22.49万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 22.49万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 22.49万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 22.49万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 22.49万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 22.49万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 22.49万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 22.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 22.49万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 22.49万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 22.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了